Correction: Association between Acid-Suppressive Drugs and Clinical Outcomes in Patients with Nonvalvular Atrial Fibrillation

Drugs R D. 2022 Sep;22(3):223. doi: 10.1007/s40268-022-00401-7. Epub 2022 Aug 18.

Hideki Arai^{1

2}, Shinichiro Ueda³, Kazutaka Uchida^{1

4}, Fumihiro Sakakibara^{1

4}, Norito Kinjo^{1

4}, Mari Nezu¹, Takeshi Morimoto⁵

¹ Department of Clinical Epidemiology, Hyogo College of Medicine, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.
² Department of Internal Medicine, Toyonaka Heisei Hospital, Toyonaka, Japan.
³ Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus, Okinawa, Japan.
⁴ Department of Neurosurgery, Hyogo College of Medicine, Nishinomiya, Japan.
⁵ Department of Clinical Epidemiology, Hyogo College of Medicine, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan. morimoto@kuhp.kyoto-u.ac.jp.

No abstract available

Publication types